Lichen sclerosus is a chronic inflammatory skin disorder that most commonly affects the anogenital region, although extragenital involvement can occur. It is characterized by thinning of the epidermis, sclerosis of the dermis, and progressive structural changes of the skin. The disease is not contagious and is not classified as a sexually transmitted infection. Lichen sclerosus can occur at any age but shows two incidence peaks: in prepubertal children and in postmenopausal adults, particularly women. Men and adolescents can also be affected, though less frequently.
Why Does Lichen Sclerosus Occur?
The exact etiology of lichen sclerosus remains a subject of ongoing medical research, but it is widely considered to be an autoimmune disorder. Current evidence suggests that the body’s immune system mistakenly attacks the structural proteins within the skin. Specifically, many patients with LS have been found to possess antibodies against extracellular matrix protein 1 (ECM1), a protein vital for skin integrity and regulation.
Genetic predisposition also plays a role, as many patients report a family history of the condition or other autoimmune diseases, such as thyroiditis, vitiligo, or alopecia areata. Hormonal factors are suspected because of the high prevalence in postmenopausal women, suggesting that low estrogen levels may influence the onset or severity of the disease.

What Symptoms Do Patients Commonly Experience?
Symptoms vary depending on age, sex, and disease severity. Pruritus is the most frequently reported symptom and can range from mild to severe, often worsening at night. Pain, burning sensations, and skin tightness are also common, particularly when fissures or erosions are present. Some patients experience dysuria, dyspareunia, or painful defecation due to involvement of adjacent structures.
In children, symptoms may be less specific and include irritation or discomfort rather than overt itching. Importantly, some individuals remain asymptomatic for long periods, and visible skin changes may be the only sign. This asymptomatic presentation underscores the need for careful clinical examination when lichen sclerosus is suspected.

How Is Lichen Sclerosus Diagnosed?
Diagnosis begins with a thorough clinical examination by a specialist, typically a dermatologist or gynecologist. While the visual signs are often characteristic, the early stages of LS can mimic other conditions like lichen planus, vitiligo, or chronic eczema. Therefore, advanced diagnostic tools and histopathological confirmation are essential for accuracy.
One of the most effective non-invasive methods used in modern clinical practice is dermoscopy. By using a high-quality dermatoscope, such as those produced by IBOOLO, clinicians can observe specific micro-structures not visible to the naked eye. Under an IBOOLO dermatoscope, such as DE-4100, LS often displays characteristic features like white structureless areas, follicular plugging, and specific vascular patterns such as dotted or glomerular vessels. This tool is invaluable for differentiating LS from other vulvar dermatoses and for monitoring the treatment response over time.

Does Dermatoscopy Replace Skin Biopsy?
Dermatoscopy does not replace histopathological examination. A skin biopsy remains the gold standard when the diagnosis is uncertain, when lesions are atypical, or when there is concern for malignant transformation. Dermoscopy cannot reliably detect dysplasia or early squamous cell carcinoma, which are critical considerations in long-standing lichen sclerosus. Instead, it serves as a complementary tool that can reduce unnecessary biopsies in clearly typical cases and help select optimal biopsy sites when needed.
What Treatments Are Currently Recommended?
High-potency topical corticosteroids are considered the first-line treatment for lichen sclerosus and are supported by strong evidence from clinical trials and long-term observational studies. When used correctly, they effectively reduce inflammation, relieve symptoms, and halt disease progression. Maintenance therapy is often required to prevent relapse.
For patients who do not tolerate or respond adequately to corticosteroids, alternative options such as topical calcineurin inhibitors may be considered, although their use requires careful monitoring. Supportive measures, including gentle skin care and avoidance of irritants, play an important role in long-term management. Treatment aims to control disease activity rather than achieve complete cure, as lichen sclerosus is typically chronic.

Can Lichen Sclerosus Lead to Serious Complications?
Long-standing lichen sclerosus, particularly in the anogenital region, is associated with an increased risk of squamous cell carcinoma. The absolute risk is relatively low, but it is clinically significant and justifies regular surveillance. Chronic inflammation and scarring are thought to contribute to malignant transformation.
Beyond malignancy, the functional complications are significant. In women, the narrowing of the vaginal opening and fusion of the clitoral hood can make sexual activity painful or impossible. In men, the scarring of the foreskin can lead to difficulty urinating or painful erections. Because of these risks, lifelong follow-up with a medical professional is mandatory for every patient diagnosed with the condition.
How Should Patients Manage Their Daily Life?
Living with lichen sclerosus requires a proactive approach to health. Regular self-examination is critical. Patients are encouraged to use a mirror once a month to inspect the area for any new changes, such as lumps, non-healing sores, or worsening white patches. Any suspicious changes should be reported to a doctor immediately.
ducation and support are equally important. Because the disease affects a private area of the body, many patients feel isolated or embarrassed. Joining support groups or seeking counseling can help manage the emotional impact of a chronic genital condition. With consistent medical care, diligent use of topical treatments, and regular monitoring with advanced diagnostic aids like IBOOLO dermatoscopes, most patients can achieve a high quality of life and effectively manage the symptoms of lichen sclerosus.